Basis: FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.
The P/S ratio is N/A as of 2026-10-06T22:19:30.315Z.
Calculation as of: 2026-10-06T22:19:30.315Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 148236961db35e193d1d700acaf87b22991c3a1a7f0bfa22e817431605aef681
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PS RATIO
N/A
Zhengye Biotechnology Holding Limited
Market Cap
$52.60M
PS Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$51.19M
PS Ratio
N/A
TTM Avg
1214.61
3Y Avg
1444.04
5Y Avg
930.10
Market Cap
$54.14M
PS Ratio
11.10
TTM Avg
47.77
3Y Avg
38.29
5Y Avg
68.25
| NAME | MARKET CAP | PS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Zhengye Biotechnology Holding Limited (ZYBT) | $52.60M | N/A | N/A | N/A | N/A |
| Spectral AI, Inc. (MDAI)vs › | $52.83M | 3.49 | 2.63 | 1.90 | 4.28 |
| Eloxx Pharmaceuticals, Inc. (ELOX)vs › | $51.99M | N/A | N/A | N/A | N/A |
| ImageneBio Inc (IMA)vs › | $51.88M | N/A | 51.20 | 31.27 | 27.74 |
| NOMAD Power Solutions, Inc. (NMAD)vs › | $53.70M | N/A | N/A | N/A | N/A |
| eXoZymes, Inc. (EXOZ)vs › | $51.23M | N/A | N/A | N/A | N/A |
| Tenax Therapeutics, Inc. (TENX)vs › | $51.19M | N/A | 1214.61 | 1444.04 | 930.10 |
| Dogwood Therapeutics, Inc. (DWTX)vs › | $51.12M | N/A | N/A | N/A | N/A |
| Rani Therapeutics Holdings, Inc. (RANI)vs › | $54.14M | 11.10 | 47.77 | 38.29 | 68.25 |
| biote Corp. (BTMD)vs › | $50.28M | 0.27 | 0.38 | 0.71 | 0.59 |
The four-quarter calculation detail is unavailable for this stored observation.
The current P/S calculation cannot be reconciled from the stored quote and revenue inputs.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
P/S Ratio
N/A
Market Cap / Trailing Twelve-Month Revenue
PS Ratio = Market Cap / Revenue (TTM)
The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
